SUN-807 - Greater Gain Predicts a Loss: Changes in Bone Density After Transitioning from Denosumab to Alendronate or Zoledronic Acid

Late-Breaking Poster Presenter(s)

• FM

  Faryal Sardar Mirza, MD, FACE

  Professor of Medicine
  UConn Health
  Farmington, Connecticut, United States

Senior Author/Primary Investigator(s)

• FM

  Faryal Sardar Mirza, MD, FACE

  Professor of Medicine
  UConn Health
  Farmington, Connecticut, United States

Co-Author(s)

• SS

  Shane Sacco, Ph.D

  Assistant Professor
  UConn Health
  Farmington, Connecticut, United States
• RZ

  Rachel Zielinski, DO

  Endocrine Fellow
  NYU Grossman School of Medicine
  New York, New York, United States
• AK

  Aysha Khan, MD

  Consultant Physician
  HOLYOKE MEDICAL CENTER
  Holyoke, Massachusetts, United States